UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers

Cancer research (Chicago, Ill.), 2007-04, Vol.67 (7), p.3441-3449

2007

Volltextzugriff (PDF)

Standardized Total Average Toxicity Score: A Scale- and Grade-Independent Measure of Late Radiotherapy Toxicity to Facilitate Pooling of Data From Different Studies

International journal of radiation oncology, biology, physics, 2012-03, Vol.82 (3), p.1065-1074

2012

Volltextzugriff (PDF)

Comparison of multiple gene expression platforms for measuring a bladder cancer hypoxia signature

Molecular medicine reports, 2022-08, Vol.26 (2), Article 261

2022

Volltextzugriff (PDF)

Perfusion Estimated With Rapid Dynamic Contrast-Enhanced Magnetic Resonance Imaging Correlates Inversely With Vascular Endothelial Growth Factor Expression and Pimonidazole Staining in Head-and-Neck Cancer: A Pilot Study

International journal of radiation oncology, biology, physics, 2011-11, Vol.81 (4), p.1176-1183

2011

Volltextzugriff (PDF)

Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinoma

European journal of cancer (1990), 2013-01, Vol.49 (1), p.156-165

2013

Volltextzugriff (PDF)

Spectral Clustering of Microarray Data Elucidates the Roles of Microenvironment Remodeling and Immune Responses in Survival of Head and Neck Squamous Cell Carcinoma

Journal of clinical oncology, 2010-06, Vol.28 (17), p.2881-2888

2010

Volltextzugriff (PDF)

An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3

European journal of cancer (1990), 2013-05, Vol.49 (7), p.1741-1751

2013

Volltextzugriff (PDF)

GLUT‐1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: Relationship to pimonidazole binding

International journal of cancer, 2003-03, Vol.104 (1), p.85-91

2003

Volltextzugriff (PDF)

Exon array analysis of head and neck cancers identifies a hypoxia related splice variant of LAMA3 associated with a poor prognosis

PLoS computational biology, 2009-11, Vol.5 (11), p.e1000571-e1000571

2009

Volltextzugriff (PDF)

Predicting tumour radiosensitivity to deliver precision radiotherapy

Nature reviews. Clinical oncology, 2023-02, Vol.20 (2), p.83-98

2023

Volltextzugriff (PDF)

A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer Patients

Clinical cancer research, 2017-08, Vol.23 (16), p.4761-4768

2017

Volltextzugriff (PDF)

Spatial proximity between T and PD-L1 expressing cells as a prognostic biomarker for oropharyngeal squamous cell carcinoma

British journal of cancer, 2020-02, Vol.122 (4), p.539-544

2020

Volltextzugriff (PDF)

A 26-Gene Hypoxia Signature Predicts Benefit from Hypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder Cancer

Clinical cancer research, 2013-09, Vol.19 (17), p.4879-4888

2013

Volltextzugriff (PDF)

hsa‐miR‐210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer

Cancer, 2010-05, Vol.116 (9), p.2148-2158

2010

Volltextzugriff (PDF)

Development and validation of a hypoxia-associated signature for lung adenocarcinoma

Scientific reports, 2022-01, Vol.12 (1), p.1290-1290, Article 1290

2022

Volltextzugriff (PDF)

Hypoxia Is Associated with Increased Immune Infiltrates and Both Anti-Tumour and Immune Suppressive Signalling in Muscle-Invasive Bladder Cancer

International journal of molecular sciences, 2023-05, Vol.24 (10), p.8956

2023

Volltextzugriff (PDF)

A miRNA signature predicts benefit from addition of hypoxia-modifying therapy to radiation treatment in invasive bladder cancer

British journal of cancer, 2021-07, Vol.125 (1), p.85-93

2021

Volltextzugriff (PDF)

Independence of HIF1a and androgen signaling pathways in prostate cancer

BMC cancer, 2020-05, Vol.20 (1), p.469-469, Article 469

2020

Volltextzugriff (PDF)

Investigation of radiosensitivity gene signatures in cancer cell lines

PloS one, 2014-01, Vol.9 (1), p.e86329-e86329

2014

Volltextzugriff (PDF)

Implementation of Oxygen Enhanced Magnetic Resonance Imaging (OE-MRI) and a Pilot Genomic Study of Hypoxia in Bladder Cancer Xenografts

Cancer genomics & proteomics, 2024-07, Vol.21 (4), p.380-387

2024

Volltextzugriff (PDF)

Low CD8 T Cell Counts Predict Benefit from Hypoxia-Modifying Therapy in Muscle-Invasive Bladder Cancer

Cancers, 2022-12, Vol.15 (1), p.41

2022

Volltextzugriff (PDF)

The hypoxia marker CAIX is prognostic in the UK phase III VorteX-Biobank cohort: an important resource for translational research in soft tissue sarcoma

British journal of cancer, 2018-03, Vol.118 (5), p.698-704

2018

Volltextzugriff (PDF)

Pretreatment plasma TGFβ1 levels are prognostic for survival but not morbidity following radiation therapy of carcinoma of the cervix

International journal of radiation oncology, biology, physics, 2000-11, Vol.48 (4), p.991-995

2000

Volltextzugriff (PDF)

Changes in oxygenation during radiotherapy in carcinoma of the cervix

International journal of radiation oncology, biology, physics, 1999-08, Vol.45 (1), p.119-126

1999

Volltextzugriff (PDF)

Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia : Correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix

Cancer research (Chicago, Ill.), 2001-09, Vol.61 (17), p.6394-6399

2001

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

ThemaTumors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

Humans
(35)
Science & Technology
(35)
Life Sciences & Biomedicine
(33)
Oncology
(30)
Biological And Medical Sciences
(24)
Medical Sciences
(23)
Female
(22)
Hypoxia
(19)
Prognosis
(13)
Male
(12)
Middle Aged
(12)
Radiation Therapy
(12)
Gynecology. Andrology. Obstetrics
(11)
Aged
(10)
Cancer
(10)
Female Genital Diseases
(9)
Gene Expression
(9)
Gene Expression Regulation, Neoplastic
(9)
Radiology, Nuclear Medicine & Medical Imaging
(9)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers

Standardized Total Average Toxicity Score: A Scale- and Grade-Independent Measure of Late Radiotherapy Toxicity to Facilitate Pooling of Data From Different Studies

Comparison of multiple gene expression platforms for measuring a bladder cancer hypoxia signature

Perfusion Estimated With Rapid Dynamic Contrast-Enhanced Magnetic Resonance Imaging Correlates Inversely With Vascular Endothelial Growth Factor Expression and Pimonidazole Staining in Head-and-Neck Cancer: A Pilot Study

Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinoma

Spectral Clustering of Microarray Data Elucidates the Roles of Microenvironment Remodeling and Immune Responses in Survival of Head and Neck Squamous Cell Carcinoma

An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3

GLUT‐1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: Relationship to pimonidazole binding

Exon array analysis of head and neck cancers identifies a hypoxia related splice variant of LAMA3 associated with a poor prognosis

Predicting tumour radiosensitivity to deliver precision radiotherapy

A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer Patients

Spatial proximity between T and PD-L1 expressing cells as a prognostic biomarker for oropharyngeal squamous cell carcinoma

A 26-Gene Hypoxia Signature Predicts Benefit from Hypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder Cancer

hsa‐miR‐210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer

Development and validation of a hypoxia-associated signature for lung adenocarcinoma

Hypoxia Is Associated with Increased Immune Infiltrates and Both Anti-Tumour and Immune Suppressive Signalling in Muscle-Invasive Bladder Cancer

A miRNA signature predicts benefit from addition of hypoxia-modifying therapy to radiation treatment in invasive bladder cancer

Independence of HIF1a and androgen signaling pathways in prostate cancer

Investigation of radiosensitivity gene signatures in cancer cell lines

Implementation of Oxygen Enhanced Magnetic Resonance Imaging (OE-MRI) and a Pilot Genomic Study of Hypoxia in Bladder Cancer Xenografts

Low CD8 T Cell Counts Predict Benefit from Hypoxia-Modifying Therapy in Muscle-Invasive Bladder Cancer

The hypoxia marker CAIX is prognostic in the UK phase III VorteX-Biobank cohort: an important resource for translational research in soft tissue sarcoma

Pretreatment plasma TGFβ1 levels are prognostic for survival but not morbidity following radiation therapy of carcinoma of the cervix

Changes in oxygenation during radiotherapy in carcinoma of the cervix

Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia : Correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix

Aktive Filter

Suchergebnisse filtern